Outcome After Laparoscopic Versus Open Pancreaticoduodenectomy
PaMIvOP
PaMIvOP
Sponsor study identifier
observational
90
0 countries
N/A
Study Start
August 1, 2016
Actual (reported)Primary Completion
September 1, 2019
Actual (reported)Study Completion
October 1, 2019
Actual (reported)Aim of the study : To determine the morbimortality of Laparoscopic pancreaticoduodenectomy (LPD) compared to the gold standard Open pancreaticoduodenectomy approach (OPD). Methods : This is a monocentric retrospective study based on a prospectively maintained clinical database. The study included 28 consecutive patients operated, between January 2016 and March 2019, of Laparoscopic pancreaticoduodenectomy (LPD) that we compared to 62 patients operated with the classical open approach by the same surgeon before the first laparoscopic resection at our institution.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 1, 2019
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 1, 2016
Actual (reported)September 1, 2019
Actual (reported)October 1, 2019
Actual (reported)May 6, 2020
Actual (reported)May 11, 2020
Actual (reported)Morbimortality of Laparoscopic pancreaticoduodenectomy (LPD)
Morbimortality of Laparoscopic pancreaticoduodenectomy (LPD) compared to the gold standard Open pancreaticoduodenectomy approach (OPD) :Overall morbidity (according to Clavien Dindo Classification)
90 postoperative days
Number of lymph nodes removed
14 postoperative days
Margins of excision
14 postoperative days
Patients requiring pancreatoduodenectomy and operated with an open approach : All consecutive patients requiring pancreato-duodenectomies for benign or malignant pathology before the first laparoscopic pancreaticoduodenectomy.
Patients requiring pancreatoduodenectomy and operated with a laparoscopic approach : All consecutive patients requiring pancreato-duodenectomies for benign or malignant pathology operated with a laparoscopic approach.
Open or laparoscopic pancreato-duodenectomy with pancreatojejunal anastomosis
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients who had Pancreatoduodenectomy with pancreatojejunal anastomosis whatever the indication
REGIS SOUCHE
University Hospital, Montpellier
90 participants (actual enrollment reported by the registry).
First Submitted
May 6, 2020
First Posted
May 11, 2020
Study Start
August 1, 2016
Actual (reported)Comparison of Chen's U-suture Technique with Duct-to-Mucosa Anastomosis and Invagination Pancreaticojejunostomy After Pancreaticoduodenectomy
Contact the study team to confirm eligibility.
Primary Completion
September 1, 2019
Actual (reported)Study Completion
October 1, 2019
Actual (reported)Last Updated
May 12, 2020
Record last verified: 2020-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: